日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Correction: Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2- advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-BRIDGE study)

更正：帕博西尼联合内分泌治疗对一线或二线治疗的 HR+/HER2- 晚期乳腺癌日本患者的总生存期：一项多中心观察性研究（P-BRIDGE 研究）

期刊:Breast Cancer
影响因子:2.9
doi:10.1007/s12282-025-01787-3
Nagai, Shigenori E; Hattori, Masaya; Yoshinami, Tetsuhiro; Masuda, Hiroko; Okamura, Takuho; Watanabe, Kenichi; Nakayama, Takahiro; Tsuneizumi, Michiko; Takabatake, Daisuke; Harao, Michiko; Yoshino, Hiroshi; Mori, Natsuko; Yasojima, Hiroyuki; Oshiro, Chiya; Iwase, Madoka; Yamaguchi, Miki; Sangai, Takafumi; Sasada, Shinsuke; Ishida, Takanori; Futamura, Manabu; Muramatsu, Yasuaki; Kosaka, Nobuyoshi; Masuda, Norikazu
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Real-world outcomes of palbociclib plus endocrine therapy in elderly patients with HR+/HER2- advanced breast cancer in Japan: a subgroup analysis of the P-BRIDGE study by age group

日本老年HR+/HER2-晚期乳腺癌患者接受帕博西尼联合内分泌治疗的真实世界疗效：P-BRIDGE研究按年龄分组的亚组分析

期刊:Breast Cancer
影响因子:2.9
doi:10.1007/s12282-025-01812-5
Masuda, Hiroko; Nagai, Shigenori E; Hattori, Masaya; Yoshinami, Tetsuhiro; Okamura, Takuho; Watanabe, Kenichi; Nakayama, Takahiro; Tsuneizumi, Michiko; Takabatake, Daisuke; Harao, Michiko; Yoshino, Hiroshi; Mori, Natsuko; Yasojima, Hiroyuki; Oshiro, Chiya; Iwase, Madoka; Yamaguchi, Miki; Sangai, Takafumi; Sasada, Shinsuke; Ishida, Takanori; Futamura, Manabu; Oda, Hirotaka; Muramatsu, Yasuaki; Masuda, Norikazu
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2026
文献求助 收藏

Electronic Patient-Reported Outcomes With Vital Sign Monitoring During Trastuzumab Deruxtecan Therapy: The PRO-DUCE Randomized Clinical Trial

曲妥珠单抗德鲁替康治疗期间生命体征监测与电子患者报告结局：PRO-DUCE随机临床试验

期刊:Jama Network Open
影响因子:9.7
doi:10.1001/jamanetworkopen.2025.27403
Kikawa, Yuichiro; Uemura, Yukari; Taira, Tetsuhiko; Kitagawa, Chiyoe; Maeda, Hideki; Kato, Hiroaki; Hashimoto, Naoki; Hosoda, Mitsuchika; Hamanaka, Yohei; Tanabe, Yuko; Yoshida, Tatsuya; Tane, Kaori; Takabatake, Daisuke; Ishikawa, Takashi; Iwamoto, Takayuki; Yamaguchi, Takeshi; Takiguchi, Daisuke; Mukai, Hirofumi; Taira, Naruto; Sangai, Takafumi
发表日期：2025
文献求助 收藏

Comparative Oncology: Cross-Sectional Single-Cell Transcriptomic Profiling of the Tumor Microenvironment Across Seven Human Cancers

比较肿瘤学：七种人类癌症肿瘤微环境的横断面单细胞转录组分析

期刊:Cancers
影响因子:4.4
doi:10.3390/cancers17213527
Okamoto, Riku; Okuno, Kota; Watanabe, Akiko; Naito, Kanako; Minoura, Hiroyuki; Shibaki, Shumpei; Ikemura, Kyonosuke; Oki, Keiko; Kuroda, Yu; Fujino, Shiori; Nie, Yusuke; Nishizawa, Nobuyuki; Watanabe, Eiichiro; Kikuchi, Mariko; Kumagai, Koshi; Yamanashi, Takahiro; Katoh, Hiroshi; Takayasu, Hajime; Sato, Takeo; Sangai, Takafumi; Kumamoto, Yusuke; Naitoh, Takeshi; Hiki, Naoki; Yamashita, Keishi
肿瘤
肿瘤免疫
Human
细胞生物学
肿瘤微环境
单细胞
发表日期：2025
文献求助 收藏

Lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion

对于伴有显著喉气管侵犯的甲状腺癌，乐伐替尼可作为紧急初始治疗方案。

期刊:European Thyroid Journal
影响因子:4.3
doi:10.1530/ETJ-25-0212
Katoh, Hiroshi; Okamoto, Riku; Ozawa, Yuka; Tokito, Takaaki; Kikuchi, Mariko; Sangai, Takafumi
甲状腺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Authors' reply to letter by Martinod et al. on rationale for using lenvatinib as an urgent initial therapy in thyroid cancer with remarkable laryngotracheal invasion

作者回复 Martinod 等人来信，信中探讨了使用乐伐替尼作为甲状腺癌伴显著喉气管侵犯患者的紧急初始治疗方案的合理性。

期刊:European Thyroid Journal
影响因子:4.3
doi:10.1530/ETJ-25-0377
Katoh, Hiroshi; Okamoto, Riku; Ozawa, Yuka; Tokito, Takaaki; Kikuchi, Mariko; Sangai, Takafumi
甲状腺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

Overall survival of palbociclib plus endocrine therapy in Japanese patients with HR+/HER2- advanced breast cancer in the first-or second-line setting: a multicenter observational study (P-BRIDGE study)

一线或二线治疗中，帕博西尼联合内分泌治疗对日本 HR+/HER2- 晚期乳腺癌患者的总生存期：一项多中心观察性研究（P-BRIDGE 研究）

期刊:Breast Cancer
影响因子:2.9
doi:10.1007/s12282-025-01689-4
Nagai, Shigenori E; Hattori, Masaya; Yoshinami, Tetsuhiro; Masuda, Hiroko; Okamura, Takuho; Watanabe, Kenichi; Nakayama, Takahiro; Tsuneizumi, Michiko; Takabatake, Daisuke; Harao, Michiko; Yoshino, Hiroshi; Mori, Natsuko; Yasojima, Hiroyuki; Oshiro, Chiya; Iwase, Madoka; Yamaguchi, Miki; Sangai, Takafumi; Sasada, Shinsuke; Ishida, Takanori; Futamura, Manabu; Muramatsu, Yasuaki; Kosaka, Nobuyoshi; Masuda, Norikazu
HER2
肿瘤
肿瘤免疫
乳腺癌
发表日期：2025
文献求助 收藏

A quantitative amplitude of vagus nerve obtained by intraoperative neuromonitoring predicts postoperative vocal cord paralysis among patients in thyroid/parathyroid surgery as a second option

术中神经监测获得的迷走神经定量振幅可预测甲状腺/甲状旁腺手术患者术后声带麻痹，作为第二选择。

期刊:Surgery Open Science
影响因子:1.7
doi:10.1016/j.sopen.2024.12.009
Katoh, Hiroshi; Okamoto, Riku; Naito, Kanako; Mitsuma, Tomoya; Kikuchi, Mariko; Tokito, Takaaki; Naitoh, Takeshi; Hiki, Naoki; Kumamoto, Yusuke; Sangai, Takafumi
免疫/内分泌
发表日期：2025
文献求助 收藏

Pathological metastatic lymph node density (ND) predicts early recurrence in papillary thyroid cancer patients after curative resection

病理转移性淋巴结密度（ND）可预测乳头状甲状腺癌患者根治性切除术后的早期复发。

期刊:Gland Surgery
影响因子:1.6
doi:10.21037/gs-2025-36
Okamoto, Riku; Katoh, Hiroshi; Naito, Kanako; Mitsuma, Tomoya; Ozawa, Yuka; Tokito, Takaaki; Kikuchi, Mariko; Yamashita, Keishi; Sangai, Takafumi
甲状腺癌
肿瘤
肿瘤免疫
免疫/内分泌
发表日期：2025
文献求助 收藏

A Case of Hypoglycemia Diagnosed by Neuropsychiatric Symptoms after Distal Gastrectomy and Total Colectomy

一例远端胃切除术和全结肠切除术后通过神经精神症状诊断的低血糖症病例

期刊:Surgical Case Reports
影响因子:0.7
doi:10.70352/scrj.cr.24-0099
Okuno, Kota; Niihara, Masahiro; Fujita, Shohei; Higuchi, Tadashi; Harada, Hiroki; Washio, Marie; Sakuraya, Mikiko; Kumagai, Koshi; Sato, Takeo; Sangai, Takafumi; Kumamoto, Yusuke; Naitoh, Takeshi; Yamashita, Keishi; Hiki, Naoki
发表日期：2025
文献求助 收藏